S&P Global
SPGI
$471.59
-0.42%
S&P Global Inc. operates as a diversified provider of credit ratings, benchmarks, market intelligence, and commodity pricing data to participants across capital and commodity markets, generating revenue through its Ratings, Market Intelligence, Indices, and Energy (Platts) segments. The company is the world's largest credit rating agency by profitability and owns iconic benchmark franchises including the S&P 500 index and Platts commodity assessments, giving it a quasi-oligopolistic moat built on regulatory recognition, brand trust, and deeply embedded data workflows. The current investor narrative centers on the July 1, 2026 spinoff of the lower-margin Mobility business (Carfax and auto data), which management and sell-side analysts frame as a catalyst for a leaner, higher-margin, recurring-revenue-focused enterprise, reinforced by a Q3 2026 earnings beat driven by Indices and Market Intelligence and raised guidance. Debate now hinges on whether the post-spinoff structural margin uplift and index/ratings cyclicality can sustain the re-rating the stock has enjoyed since its October lows, particularly as issuance activity and passive asset flows remain the key swing factors for the Ratings and Indices franchises.…
SPGI
S&P Global
$471.59
Related headlines
Investment Opinion: Should I buy SPGI Today?
Rating: Buy. S&P Global is a high-quality compounder whose Q3 2026 results (operating margin 53.2% vs. 43.1% a year ago, EPS +10.1% to $4.25) demonstrate that the July 1 Mobility spinoff is genuinely re-rating the earnings base, and the sell-side consensus of 22 Buy / 1 Hold / 0 Sell with a $526.70 average target (+11.2% from $473.59) confirms broad conviction. The core thesis is that investors are buying a leaner, higher-margin oligopoly — Ratings, Indices, Market Intelligence, and Platts — whose recurring revenue and 59.4% EBITDA margin justify a premium multiple even as the reported top line temporarily shrinks.
Supporting evidence is strong across four dimensions: the forward PE of 23.5x sits 30% below the 33.7x trailing multiple and implies roughly 44% EPS growth toward the $26.96 consensus 2027 estimate, a PEG of 1.80 is reasonable for a franchise with 71.9% gross and 29.2% net margins, trailing free cash flow of $5.641 billion (3.7% FCF yield) funded $2.6 billion of Q3 buybacks plus $281 million of dividends, and the stock's +15.91% one-month return versus SPY's -2.26% (relative strength +18.17) reflects idiosyncratic catalysts rather than beta. Even the lowest analyst target of $485.00 sits above the current price, an unusually strong floor of published conviction.
Three risks could invalidate the thesis: a 5.4% consolidated revenue decline that leaves earnings dependent entirely on margin expansion, a 33.7x trailing multiple in the upper-middle of its 21.4x–41.3x two-year band that limits re-rating headroom, and cyclical exposure to debt issuance and passive flows. The rating would upgrade to a higher-conviction Buy if Ratings issuance recovers and operating margins hold above 50% into 2027, and would downgrade to Hold if revenue declines persist beyond the post-spinoff base normalization or if the forward PE expands above 28x without matching EPS delivery. On balance, at 23.5x forward earnings with a 3.7% FCF yield and an 11.2% consensus upside, the stock is fairly valued to modestly undervalued relative to its own history and its franchise quality — a Buy for long-term investors, not a momentum chase.
Sign up to view all
SPGI 12-Month Price Forecast
The forward view is constructive but not euphoric: the post-spinoff earnings base is materially higher-quality, with 53.2% operating margins and 59.4% EBITDA margins converting a shrinking top line into 10.1% EPS growth, and the 23.5x forward multiple is defensible for an oligopoly franchise with 71.9% gross margins. The 55% base-case probability reflects that the most likely path is a grind toward the $526.70 average target as revenue growth normalizes and margins hold, while the 25% bull case requires issuance recovery and multiple expansion to the $572.00 high target. The 20% bear case is real given the -29.3% maximum drawdown history and the 33.7x trailing multiple's position in the upper-middle of its band, but the $5.641 billion FCF and $2.6 billion quarterly buyback pace provide a valuation floor. I would upgrade to high confidence if Ratings revenue returns to positive growth and margins hold above 50% for two quarters, and would downgrade to neutral if consolidated revenue declines persist beyond the spinoff comp or if the forward PE expands above 28x without matching EPS delivery.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on S&P Global's 12-month outlook, with a consensus price target around $526.70 and implied upside of +11.7% versus the current price.
Average Target
$526.70
23 analysts
Implied Upside
+11.7%
vs. current price
Analyst Count
23
covering this stock
Price Range
$485 - $572
Analyst target range
Coverage is deep and overwhelmingly bullish: 20 analysts contribute to the consensus, with 22 Buy ratings, 1 Hold, and 0 Sells, producing a recommendation of "strong_buy" and a recommendation mean of 1.35 (where 1.0 is a strong buy). The average target price of $526.70 implies +11.2% upside from the current $473.59, and notably the lowest target of $485.00 sits above the current price — meaning every published analyst target implies positive return, an unusually strong signal of conviction. Recent institutional actions reinforce the tone, with Barclays, Evercore ISI, Morgan Stanley, Wells Fargo, Citigroup, JP Morgan, BMO, and Mizuho all reiterating Overweight/Outperform/Buy ratings through October and early November 2026, with no downgrades in the visible record.
The target range of $485.00 to $572.00 spans roughly 18% and is relatively tight for a large-cap, signaling strong consensus rather than dispersed uncertainty. The high target of $572.00 (about +20.8% upside) likely assumes successful execution of the post-spinoff margin story, continued index-asset inflows, a recovery in debt issuance volumes, and multiple expansion toward the higher end of the historical PE band. The low target of $485.00 (+2.4% upside) still embeds modest appreciation and appears to price in a more conservative scenario of flat issuance activity and margin stabilization without further re-rating — the absence of any target below the current price underscores that even the bear case among covering analysts is constructive, though investors should note that such uniform bullishness can itself be a contrarian caution flag after a 22% rally from the October lows.
Bulls vs Bears: SPGI Investment Factors
The bull case currently holds the stronger evidence: margins have structurally inflected (53.2% operating versus 43.1% a year ago), EPS is growing 10.1% despite a shrinking top line, free cash flow of $5.641 billion funds $2.6 billion of quarterly buybacks, and all 23 analyst ratings are Buy or Hold with every target above the current price. The bear case rests less on fundamentals than on positioning and cyclicality — a 5.4% consolidated revenue decline, a 33.7x trailing multiple in the upper-middle of its two-year band, and a uniformly bullish sell-side that leaves little room for positive surprise after a 22% rally. The single most important tension is whether the post-spinoff margin uplift is a durable structural re-rating or merely a mix artifact that reverses when debt issuance volumes normalize — if Ratings issuance recovers and margins hold above 50%, the forward 23.5x multiple looks cheap; if issuance stays soft and margins mean-revert, the trailing premium becomes the binding constraint. Investors are effectively being asked to pay today for an earnings base that will only be visible in 2027.
Bullish
- Unanimous analyst conviction, all targets above price: 22 of 23 ratings are Buy with zero Sells and a recommendation mean of 1.35, and the lowest published target of $485.00 sits above the current $473.59 — meaning every covering analyst models a positive return. The $526.70 average target implies +11.2% upside, and the tight $485–$572 range (18% spread) signals consensus rather than dispersed uncertainty.
- Margin transformation from Mobility spinoff is real: Q3 2026 operating margin hit 53.2%, up from 43.1% in Q3 2025 and 36.4% in Q4 2024, while EBITDA margin reached 59.4% and gross margin 71.9%. Diluted EPS of $4.25 grew 10.1% year-over-year despite a 5.4% revenue decline, proving the mix shift toward high-margin Indices and Market Intelligence is converting directly into earnings.
- Forward multiple resets to a reasonable 23.5x: The 33.7x trailing PE compresses to 23.5x forward, a 30% discount that implies the market expects roughly 44% EPS growth toward the $26.96 consensus 2027 estimate. A PEG of 1.80 and EV/EBITDA of 21.2x are defensible for a business with 59.4% EBITDA margins and oligopoly-protected recurring revenue.
- Momentum reversal with strong relative strength: The stock is up 15.91% in one month and 13.08% in three months versus SPY at -2.26% and -2.83%, producing relative strength of +18.17 and +15.91 respectively. With beta of 1.033, this outperformance is idiosyncratic — driven by the spinoff completion, the Q3 beat, and raised guidance — not market leverage.
Bearish
- Consolidated revenue is shrinking, not growing: Q3 2026 revenue of $3.678 billion fell 5.4% year-over-year and has slid sequentially from $4.171 billion in Q1 to $4.146 billion in Q2. Even accounting for the July 1 Mobility spinoff, the Ratings segment at $1.271 billion faced softer issuance volumes, and the top line will stay optically challenged until the post-spinoff base normalizes.
- Uniform bullishness is a contrarian warning: Zero Sell ratings and a lowest target above spot after a 22% rally from the October lows of roughly $386 is a crowded-consensus setup. When every analyst already models upside, there is little room for positive surprise, and a single guidance miss could force a synchronized round of downgrades.
- Valuation sits in the upper-middle of its band: The 33.7x trailing PE is well above the 21.4x trough recorded in Q1 2026 and only moderately below the 41.3x 2024 peak, while EV/Sales of 9.45x and PCF of 26.7x are rich in absolute terms. If issuance volumes disappoint, the trailing premium limits multiple expansion even as the forward story stays intact.
- Cyclical exposure to issuance and asset flows: Ratings revenue depends on debt issuance volumes and Indices revenue on passive asset flows — both market-cycle variables outside management control. The Q3 beat came from Indices and Market Intelligence precisely because Ratings was soft, illustrating how a single weak franchise can offset strength elsewhere.
SPGI Technical Analysis
S&P Global is in a powerful recovery uptrend following a difficult first half of 2026, with the stock closing at $473.59 against a 52-week range of $361.03 to $522.47 — positioning it at roughly 69.7% of its 52-week range. The 1-year price change of -5.84% masks a sharp inflection: the stock bottomed near $386 in early October and has since rallied more than 22%, while the maximum drawdown of -29.3% over the trailing period illustrates how severe the earlier de-rating was. This positioning — well off the lows but still 9.4% below the 52-week high — suggests the stock is in a momentum-driven repair phase rather than an overextended blow-off top.
Short-term momentum is decisively positive and accelerating: the 1-month change of +15.91% and 3-month change of +13.08% both dwarf the 6-month gain of +17.47%, meaning the bulk of the move has been compressed into the last several weeks. The divergence with the 1-year trend (-5.84%) is stark and signals a genuine trend reversal rather than a mean-reversion bounce, corroborated by relative strength versus SPY of +18.17 over one month and +15.91 over three months, against a 1-year relative strength of -18.11. The stock's beta of 1.033 indicates volatility roughly in line with the market, so the recent outperformance is driven by idiosyncratic catalysts — the spinoff completion, the Q3 beat, and raised guidance — rather than leverage to market beta.
Key technical levels are well defined: support sits at the 52-week low of $361.03, with intermediate support around the October breakout zone near $410–$425, while resistance is the 52-week high of $522.47, roughly 10.3% above the current price. A breakout above $522.47 would confirm a full trend reversal and likely trigger momentum-fund accumulation, whereas a breakdown below $425 would invalidate the October breakout and refocus attention on the $386 lows. With a beta of 1.033 and a short ratio of 2.22 (light short interest), the risk profile is moderate — position sizing should account for the stock's history of sharp 29.3% drawdowns even in structurally sound franchises.
Beta
1.03
1.03x market volatility
Max Drawdown
-29.3%
Largest decline past year
52-Week Range
$361-$522
Price range past year
Annual Return
-4.5%
Cumulative gain past year
| Period | SPGI Return | S&P 500 |
|---|---|---|
| 1m | +9.8% | -3.0% |
| 3m | +12.8% | -3.6% |
| 6m | +13.1% | -0.2% |
| 1y | -4.5% | +10.1% |
| ytd | -8.0% | +8.5% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
SPGI Fundamental Analysis
Revenue trajectory has decelerated markedly: Q3 2026 revenue of $3.678 billion declined 5.4% year-over-year versus $3.888 billion in Q3 2025, continuing a sequential slide from $4.171 billion in Q1 and $4.146 billion in Q2 2026 — a pattern heavily distorted by the July 1 Mobility spinoff, which removed a revenue-contributing segment from the consolidated base. Within the remaining portfolio, the Ratings segment ($1.271 billion) and Market Intelligence ($1.263 billion) are the twin engines, with Indices contributing $554 million; the Q3 beat was attributed to strength in Indices and Market Intelligence, implying Ratings faced softer issuance volumes. The organic growth picture is therefore better than the headline -5.4% suggests, but the consolidated top line will remain optically challenged until the post-spinoff base normalizes.
Profitability is exceptional and improving: Q3 2026 net income of $1.24 billion on a 33.7% net margin, gross margin of 71.9%, and operating margin of 53.2% — the latter up sharply from 43.1% in Q3 2025 and 36.4% in Q4 2024, reflecting both operating leverage and the removal of lower-margin Mobility revenue. EBITDA of $2.184 billion equates to a 59.4% EBITDA margin, and diluted EPS of $4.25 grew 10.1% year-over-year from $3.86 despite the revenue decline, evidence that mix shift toward high-margin data and index products is working. These margins are best-in-class for financial data and exchange operators, where gross margins in the 60–70% range are typical but 50%+ operating margins are reserved for the elite franchise names.
Balance sheet and cash generation are solid: debt-to-equity of 0.455, interest coverage of roughly 22.5x, and trailing free cash flow of $5.641 billion against a $150.7 billion market cap imply an FCF yield of about 3.7%. The current ratio of 0.824 is below 1.0, a function of the capital-light model and heavy buyback activity — Q3 2026 alone saw $2.6 billion of stock repurchased alongside $281 million of dividends, funded comfortably by $1.556 billion of quarterly operating cash flow. ROE of 14.3% and ROA of 8.3% are respectable though below the company's historical peak, and the low capex intensity ($28 million in Q3) means nearly all operating cash converts to free cash flow, leaving ample internal funding capacity without external financing dependence.
Quarterly Revenue
$3.7B
2026-09
Revenue YoY Growth
-5.4%
YoY Comparison
Gross Margin
71.9%
Latest Quarter
Free Cash Flow
$5.6B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is SPGI Overvalued?
Because S&P Global is solidly profitable (Q3 2026 net income of $1.24 billion), the PE ratio is the appropriate primary metric: the stock trades at 33.7x trailing earnings versus 23.5x forward earnings, a 30% compression that implies the market expects roughly 44% EPS growth — consistent with consensus 2027 EPS estimates of $26.96 against the current run-rate. The forward multiple of 23.5x is the more decision-relevant figure and sits at a meaningful discount to the trailing multiple, signaling that analysts view the post-spinoff earnings base as materially higher-quality and faster-growing than the reported history suggests.
Relative to the Financial Data & Stock Exchanges industry, the 33.7x trailing PE and 9.83x PS represent a premium positioning consistent with the company's franchise quality, though precise industry-average multiples are not available in the provided data for a quantified spread. The EV/EBITDA of 21.2x and EV/Sales of 9.45x are rich on an absolute basis but defensible given 59.4% EBITDA margins and the oligopoly structure of ratings and index provision; the PEG ratio of 1.80 suggests the growth-adjusted valuation is reasonable rather than stretched. The 70.2% gross margin and 29.2% net margin support the premium — few financial-data peers combine this level of profitability with regulatory-moat-protected recurring revenue.
Historically, the stock's PE has ranged from roughly 21.4x (Q1 2026) to 41.3x (Q4 2024) over the past two years, with the current 33.7x trailing multiple sitting in the upper-middle of that band but well below the 2024 peak. The PS ratio of 9.83x, however, is dramatically below the 27x–42x range recorded across 2024–2026 in the historical ratios data — a discrepancy that likely reflects the post-spinoff share-count and revenue-base reset rather than a genuine valuation collapse, and investors should treat the historical PS series with caution. On balance, the current valuation prices in optimistic but not euphoric expectations: the forward PE of 23.5x leaves room for multiple expansion if margin guidance is met, while the trailing premium limits upside if issuance volumes disappoint.
PE
33.7x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range 21x~41x
vs. Industry Avg
32.4x
Industry PE ~32.4x*
EV/EBITDA
21.2x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks center on the revenue contraction and the dependence on mix to sustain earnings growth. Q3 2026 revenue of $3.678 billion declined 5.4% year-over-year and has fallen sequentially for two straight quarters from $4.171 billion, meaning the 10.1% EPS growth to $4.25 is being carried entirely by margin expansion rather than top-line momentum. The current ratio of 0.824 sits below 1.0 after $2.6 billion of Q3 buybacks, and while debt-to-equity of 0.455 and interest coverage near 22.5x are comfortable, the aggressive repurchase pace leaves less balance-sheet cushion if operating cash flow of $1.556 billion per quarter slows. Revenue concentration compounds this: Ratings ($1.271 billion) and Market Intelligence ($1.263 billion) together represent roughly 69% of segment revenue, so a soft issuance cycle in either franchise flows almost directly to the bottom line. Market and competitive risks revolve around valuation compression and cyclical sensitivity. At 33.7x trailing earnings, 9.45x EV/Sales, and 21.2x EV/EBITDA, the stock trades at a premium that assumes the post-spinoff margin story executes cleanly; a re-rating toward the 21.4x PE trough seen in Q1 2026 would imply roughly a 36% multiple compression even with flat earnings. Beta of 1.033 means the shares move with the market rather than offering defensive ballast, and the Ratings and Indices franchises are directly levered to debt issuance volumes and passive fund flows — both of which tighten sharply in risk-off regimes. The recent news flow is supportive (Q3 beat on Indices and Market Intelligence, raised guidance, the July 1 Mobility spinoff), but it also explains why expectations are elevated, and the absence of any Sell rating means downgrades, not upgrades, are the asymmetric surprise. The worst-case scenario is a synchronized issuance drought combined with multiple compression: soft debt issuance depresses Ratings revenue, equity market weakness slows index asset flows, and the 53.2% operating margin proves to be a mix artifact rather than a structural plateau. In that chain, the stock would retest its 52-week low of $361.03, roughly -23.8% from the current $473.59, consistent with the -29.3% maximum drawdown already experienced over the trailing period. A more moderate adverse case would see shares drift toward the October breakout zone of $410–$425, a -10% to -13% move, while a break below $425 would technically invalidate the recovery and refocus attention on the $386 lows.
FAQ
Ranked by severity: first, revenue contraction and margin dependence — Q3 2026 revenue of $3.678 billion fell 5.4% year-over-year and has declined sequentially from $4.171 billion in Q1, so the entire 10.1% EPS growth to $4.25 rests on margin expansion that could mean-revert. Second, valuation compression — the 33.7x trailing PE and 21.2x EV/EBITDA leave limited re-rating headroom, and a move toward the 21.4x Q1 2026 trough would cut the share price by roughly a third on unchanged earnings. Third, cyclical exposure to debt issuance volumes and passive asset flows, which drive the Ratings ($1.271 billion) and Indices ($554 million) franchises and are outside management control, as the Q3 beat on Indices and Market Intelligence offsetting soft Ratings illustrates. Fourth, positioning and balance-sheet risk — zero Sell ratings after a 22% rally from the October lows creates asymmetric downgrade risk, and a current ratio of 0.824 after $2.6 billion of quarterly buybacks leaves less cushion if the $1.556 billion quarterly operating cash flow slows.
The base case carries 55% probability and targets $485.00–$526.70, assuming the post-spinoff base normalizes, margins hold in the 50%–53% range, forward PE stays near 23.5x, and shares grind toward the $526.70 average target as roughly $27 of forward EPS materializes. The bull case at 25% probability targets $526.70–$572.00 and requires debt issuance volumes to normalize, Ratings revenue to reaccelerate, index inflows to lift Indices above the $554 million Q3 base, and the forward multiple to expand toward the upper end of its historical band. The bear case at 20% probability targets $361.03–$425.00, driven by an issuance drought, equity market weakness slowing index flows, and the 53.2% margin proving a mix artifact that mean-reverts while the multiple compresses toward the 21.4x trough. The base case is most likely, and its key assumption is that the margin uplift is structural rather than a one-quarter mix effect — the 55/25/20 split implies a roughly 80% chance of shares at or above the current $473.59 within twelve months.
The decision-relevant metric is the forward PE of 23.5x, which sits 30% below the 33.7x trailing multiple and implies roughly 44% EPS growth toward the $26.96 consensus 2027 estimate — a reasonable price for a franchise with 71.9% gross and 29.2% net margins and a PEG of 1.80. On absolute measures the stock is not cheap: EV/EBITDA of 21.2x, EV/Sales of 9.45x, PS of 9.83x, and PCF of 26.7x all embed premium-franchise assumptions, and the 33.7x trailing PE sits in the upper-middle of the 21.4x (Q1 2026) to 41.3x (Q4 2024) two-year band. Relative to its own history the stock is therefore fairly valued to modestly undervalued on forward earnings but not discounted on trailing metrics, and the 3.7% FCF yield provides a modest valuation floor. What the market is pricing is a durable structural margin uplift from the Mobility spinoff rather than further revenue acceleration — if the 53.2% operating margin proves a mix artifact and reverts toward 43%, a de-rating toward the 21.4x trough would imply roughly 36% multiple compression even on flat earnings.
From a risk/reward standpoint the setup is favorable but not exceptional: at $473.59 the stock offers +11.2% upside to the $526.70 average target and +20.8% to the $572.00 high target, while the lowest published target of $485.00 still sits above spot, meaning all 23 covering ratings (22 Buy, 1 Hold, 0 Sell) imply positive returns. The downside is quantifiable at roughly -23.8% to the $361.03 52-week low in a synchronized issuance-drought and multiple-compression scenario, and the stock has already demonstrated a -29.3% maximum drawdown over the trailing period. The quality of the earnings base is the strongest argument — 53.2% operating margin, 59.4% EBITDA margin, and $5.641 billion of trailing free cash flow — but the 5.4% consolidated revenue decline means near-term returns depend on margin durability rather than top-line growth. It is a good buy for long-term investors comfortable with a 33.7x trailing multiple in the upper-middle of its 21.4x–41.3x two-year band and willing to underwrite the post-spinoff margin story into 2027; it is a poorer buy for short-term traders chasing a stock already up 15.91% in a month with a crowded, uniformly bullish sell-side.
The profile favors long-term holding: this is a mature, capital-light oligopoly with 71.9% gross margins, $5.641 billion of trailing free cash flow, and a 0.78% dividend yield with a conservative 26.2% payout ratio, meaning returns come from earnings compounding and buybacks rather than income or rapid growth. Beta of 1.033 offers no defensive ballast, and the -29.3% maximum drawdown alongside a 52-week range of $361.03 to $522.47 shows the shares can de-rate sharply in risk-off tapes, so short-term traders face meaningful drawdown risk with a short ratio of only 2.22 offering little squeeze potential. Earnings visibility is high given recurring data and index revenue, but the 5.4% revenue decline and pending post-spinoff comp normalization mean the next two to three quarters carry elevated headline noise. A minimum holding period of 18–24 months is appropriate — long enough for the 2027 EPS base of roughly $26.96 to be validated and for the margin story to be proven across multiple quarters, consistent with the 55% base-case probability of a grind toward $526.70.

